ozempic teeth: dentists warn of new glp-1 side effect What Want You to Know About the Dental Effects Drugs Dentists warn of new GLP-1

GIP/GLP-1/Glucagon Receptor Triple Agonists Retatrutide, a long-acting agonist targeting glucagon, GIP, and GLP-1 receptors, has been tested in clinical trials involving human participants

All GLP-1 agonists labeled for weight reduction in cases of obesity or overweight plus one weight-related comorbidity must be combined with a reduced-calorie diet and increased physical activity

2) Neurodegenerative Diseases: A Glimmer of Hope for Cognitive and Motor Function GLP-1 medications are emerging as potential neuroprotective agents, offering a glimmer of hope for individuals battling devastating neurodegenerative diseases such as Alzheimer's and Parkinson's

The decline comes as a growing number of Americans turn to GLP-1 drugs to lose weight

Aliment Pharmacol Ther 2000